Everence Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.32M Sell
3,392
-1,428
-30% -$570K 0.07% 208
2026
Q2
$1.86M Hold
4,820
– – 0.1% 160
2026
Q1
$1.41M Sell
4,820
-464
-9% -$152K 0.09% 191
2025
Q4
$1.85M Sell
5,284
-1,138
-18% -$385K 0.11% 147
2025
Q3
$2.08M Sell
6,422
-958
-13% -$298K 0.12% 136
2025
Q2
$2.87M Sell
7,380
-660
-8% -$265K 0.18% 102
2025
Q1
$3.5M Buy
8,040
+530
+7% +$213K 0.24% 83
2024
Q4
$2.77M Sell
7,510
-1,500
-17% -$628K 0.18% 94
2024
Q3
$4.68M Hold
9,010
– – 0.3% 57
2024
Q2
$4.76M Hold
9,010
– – 0.33% 50
2024
Q1
$4.67M Hold
9,010
– – 0.31% 56
2023
Q4
$4.25M Buy
9,010
+2,210
+33% +$1.02M 0.3% 61
2023
Q3
$2.96M Buy
6,800
+890
+15% +$404K 0.23% 85
2023
Q2
$2.65M Hold
5,910
– – 0.22% 90
2023
Q1
$2.72M Sell
5,910
-1,600
-21% -$761K 0.22% 91
2022
Q4
$3.85M Buy
7,510
+190
+3% +$96.5K 0.33% 53
2022
Q3
$3.32M Hold
7,320
– – 0.31% 62
2022
Q2
$3.53M Hold
7,320
– – 0.32% 64
2022
Q1
$3.6M Hold
7,320
– – 0.28% 75
2021
Q4
$3.39M Hold
7,320
– – 0.25% 67
2021
Q3
$2.73M Hold
7,320
– – 0.22% 80
2021
Q2
$2.8M Hold
7,320
– – 0.23% 81
2021
Q1
$2.63M Buy
7,320
+370
+5% +$119K 0.24% 73
2020
Q4
$2.23M Buy
6,950
+930
+15% +$285K 0.22% 76
2020
Q3
$1.62M Hold
6,020
– – 0.18% 104
2020
Q2
$1.77M Hold
6,020
– – 0.21% 88
2020
Q1
$1.37M Hold
6,020
– – 0.19% 91
2019
Q4
$1.82M Buy
6,020
+830
+16% +$228K 0.27% 75
2019
Q3
$1.25M Hold
5,190
– – 0.2% 111
2019
Q2
$1.46M Hold
5,190
– – 0.24% 96
2019
Q1
$1.49M Sell
5,190
-1,431
-22% -$414K 0.26% 91
2018
Q4
$1.74M Buy
6,621
+670
+11% +$184K 0.4% 66
2018
Q3
$1.63M Hold
5,951
– – 0.32% 74
2018
Q2
$1.42M Hold
5,951
– – 0.3% 79
2018
Q1
$1.31M Hold
5,951
– – 0.29% 86
2017
Q4
$1.34M Buy
5,951
+481
+9% +$102K 0.29% 86
2017
Q3
$1.04M Hold
5,470
– – 0.24% 123
2017
Q2
$1.03M Hold
5,470
– – 0.25% 114
2017
Q1
$905K Hold
5,470
– – 0.24% 119
2016
Q4
$786K Buy
5,470
+1,170
+27% +$157K 0.23% 128
2016
Q3
$539K Hold
4,300
– – 0.16% 180
2016
Q2
$565K Buy
+4,300
New +$588K 0.17% 172
2015
Q4
– Sell
-5,655
Closed -$792K – 300
2015
Q3
$792K Hold
5,655
– – 0.27% 109
2015
Q2
$928K Hold
5,655
– – 0.3% 102
2015
Q1
$828K Hold
5,655
– – 0.28% 112
2014
Q4
$711K Hold
5,655
– – 0.24% 123
2014
Q3
$659K Hold
5,655
– – 0.24% 135
2014
Q2
$609K Hold
5,655
– – 0.23% 140
2014
Q1
$563K Hold
5,655
– – 0.22% 141
2013
Q4
$522K Sell
5,655
-1,290
-19% -$115K 0.21% 147
2013
Q3
$581K Hold
6,945
– – 0.25% 121
2013
Q2
$568K Hold
6,945
– – 0.26% 112

Other funds holding ELV

Everence Capital Management's ELV Position: Q3 2026 in Review

Everence Capital Management reduced its Elevance Health (ELV) stake by 30% in Q3 2026, selling an estimated $570K and leaving 3,392 shares worth $1.32M. The position accounts for 0.07% of the portfolio, ranked #208.

Everence Capital Management first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.76M in Q2 2024. 1,627 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Everence Capital Management held 3,392 shares of Elevance Health worth $1.32M as of Q3 2026.
  • Everence Capital Management sold 1,428 Elevance Health shares in Q3 2026, an estimated $570K.
  • Elevance Health made up 0.07% of Everence Capital Management's portfolio in Q3 2026, its #208 holding.
  • Everence Capital Management first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • Everence Capital Management's Elevance Health position peaked at $4.76M in Q2 2024.
  • 1,627 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Everence Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.